CLSI MM03A2

Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline, MM03-A2

Clinical and Laboratory Standards Institute, 02/17/2006

Publisher: CLSI

File Format: PDF

$142.00$285.63

Description

Published:17/02/2006

Pages:88

This guideline addresses topics relating to clinical applications, amplified and nonamplified nucleic acid methods, selection and qualification of nucleic acid sequences, establishment and evaluation of test performance characteristics, inhibitors, and interfering substances, controlling false-positive reactions, reporting and interpretation of results, quality assurance, regulatory issues, and recommendations for manfactuers and clinical laboratories.

More CLSI standard pdf

CLSI GP34-A (R2018)

Tubes and Additives for Venous and Capillary Blood Specimen Collection; Approved Guideline, GP34A

$90.00 $180.00

CLSI POCT08-A (R2018)

Quality Practices in Noninstrumented Near-Patient Testing: An Instructional Manual and Resources for Health Care Workers; Approved Guideline, POCT08AE

$90.00 $180.00

CLSI MM06-A2 (R2018)

Quantitative Molecular Methods for Infectious Diseases; Approved Guideline, MM06A2E

$90.00 $180.00

CLSI POCT07-A (R2018)

Quality Management: Approaches to Reducing Errors at the Point of Care; Approved Guideline, POCT07AE

$90.00 $180.00